The ANTHEM-UC Study is evaluating the efficacy and safety of an oral investigational medication for the treatment of moderately to severely active ulcerative colitis (UC).
See If You Are EligibleThere have been a growing number of approved treatments for UC over the years, thanks to clinical research and those who have participated. Although some of the approved treatments for UC are delivered intravenously (through a vein), the ANTHEM-UC Study will explore whether an investigational medication delivered orally (by mouth) is effective and safe.
You may be able to take part in the ANTHEM-UC Study if you:
Additional eligibility criteria will be assessed by the study doctor or staff.
SEE IF YOU ARE ELIGIBLE